- Home
- FBK vs TARS Comparison
FBK vs TARS Comparison
Compare FBK & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBK
- TARS
- Stock Information
- Founded
- FBK 1906
- TARS 2016
- Country
- FBK United States
- TARS United States
- Employees
- FBK N/A
- TARS N/A
- Industry
- FBK Major Banks
- TARS Medicinal Chemicals and Botanical Products
- Sector
- FBK Finance
- TARS Health Care
- Exchange
- FBK Nasdaq
- TARS Nasdaq
- Market Cap
- FBK 2.1B
- TARS 1.8B
- IPO Year
- FBK 2016
- TARS 2020
- Fundamental
- Price
- FBK $43.10
- TARS $40.65
- Analyst Decision
- FBK Hold
- TARS Strong Buy
- Analyst Count
- FBK 5
- TARS 7
- Target Price
- FBK $54.00
- TARS $67.14
- AVG Volume (30 Days)
- FBK 171.1K
- TARS 552.3K
- Earning Date
- FBK 07-14-2025
- TARS 08-07-2025
- Dividend Yield
- FBK 1.77%
- TARS N/A
- EPS Growth
- FBK 14.69
- TARS N/A
- EPS
- FBK 2.73
- TARS N/A
- Revenue
- FBK $465,280,000.00
- TARS $233,674,000.00
- Revenue This Year
- FBK $35.47
- TARS $122.94
- Revenue Next Year
- FBK $20.14
- TARS $44.14
- P/E Ratio
- FBK $15.69
- TARS N/A
- Revenue Growth
- FBK 2.18
- TARS 449.03
- 52 Week Low
- FBK $36.26
- TARS $20.08
- 52 Week High
- FBK $58.88
- TARS $57.28
- Technical
- Relative Strength Index (RSI)
- FBK 45.56
- TARS 40.26
- Support Level
- FBK $42.29
- TARS $39.25
- Resistance Level
- FBK $43.88
- TARS $42.01
- Average True Range (ATR)
- FBK 0.80
- TARS 1.93
- MACD
- FBK -0.08
- TARS -0.05
- Stochastic Oscillator
- FBK 35.46
- TARS 22.95
About FBK FB Financial Corporation
FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.